{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:33:50Z","timestamp":1793100830191,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["WXLHCXJJ25-05"],"award-info":[{"award-number":["WXLHCXJJ25-05"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171182"],"award-info":[{"award-number":["32171182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC0627"],"award-info":[{"award-number":["2025ZNSFSC0627"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.semcancer.2026.102621","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:52:39Z","timestamp":1790265159000},"page":"102621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic drivers of bidirectional heart\u2013cancer crosstalk: From a relatively tumor-restrictive myocardium to therapeutic decoupling"],"prefix":"10.1016","volume":"127","author":[{"given":"Zili","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-1552","authenticated-orcid":false,"given":"Wanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-3377","authenticated-orcid":false,"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-5605","authenticated-orcid":false,"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091483","article-title":"Emerging Trends in Global Cancer Epidemiology","volume":"17","author":"Raza","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"10440","key":"10.1016\/j.semcancer.2026.102621_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2024-000909","article-title":"Associations between cardiometabolic comorbidities and mortality in adults with cancer: multinational cohort study","volume":"4","author":"Davila-Batista","year":"2025","journal-title":"BMJ Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study","volume":"80","author":"Florido","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2026.102621_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2025.05.009","article-title":"Metabolic reprogramming in cancer therapy-related cardiovascular toxicity: Mechanisms and intervention strategies","volume":"113","author":"Zeng","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/med.21476","article-title":"C.H.K. Researchers, Collaborators, Comprehensive review of cardiovascular toxicity of drugs and related agents","volume":"38","author":"Mladenka","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","article-title":"Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis","volume":"10","author":"Nielsen","year":"2024","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the international cardio-oncology society","volume":"3","author":"Mitchell","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ejhf.472","article-title":"Incidence of cancer in patients with chronic heart failure: a long-term follow-up study","volume":"18","author":"Banke","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead073","article-title":"Association between heart failure and the incidence of cancer: a systematic review and meta-analysis","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur. Heart J. Open."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaccao.2021.11.007","article-title":"Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort","volume":"4","author":"Bertero","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaccao.2024.08.008","article-title":"Incident Myocardial Infarction, Heart Failure, and Oncologic Outcomes in Breast Cancer Survivors","volume":"6","author":"Calvillo-Arguelles","year":"2024","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12872-018-0932-z","article-title":"Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study","volume":"18","author":"Malmborg","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac Energy Metabolism in Heart Failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cmet.2024.06.003","article-title":"Human cardiac metabolism","volume":"36","author":"Bornstein","year":"2024","journal-title":"Cell. Metab."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00395-007-0666-z","article-title":"B. O'Rourke, Excitation-contraction coupling and mitochondrial energetics","volume":"102","author":"Maack","year":"2007","journal-title":"Basic. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trecan.2019.11.009","article-title":"Metabolic Fitness and Plasticity in Cancer Progression","volume":"6","author":"McGuirk","year":"2020","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib20","first-page":"587","article-title":"Forward and reverse cardio-oncology","volume":"106","author":"Meijers","year":"2026","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaccao.2025.05.014","article-title":"Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form Primer","volume":"7","author":"de Boer","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib22","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2024.06.008","article-title":"Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype","volume":"194","author":"Ogilvie","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart Failure Stimulates Tumor Growth by Circulating Factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib24","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming","volume":"26","author":"Koelwyn","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1101\/gad.231233.113","article-title":"D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice","volume":"28","author":"Akbay","year":"2014","journal-title":"Genes. Dev."},{"issue":"37","key":"10.1016\/j.semcancer.2026.102621_bib26","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1073\/pnas.1601650113","article-title":"Oncometabolite d-2-hydroxyglutarate impairs alpha-ketoglutarate dehydrogenase and contractile function in rodent heart","volume":"113","author":"Karlstaedt","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102621_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacbts.2021.05.008","article-title":"Cardio-oncology: understanding the intersections between cardiac metabolism and cancer biology","volume":"6","author":"Karlstaedt","year":"2021","journal-title":"JACC Basic. Transl. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-025-01119-w","article-title":"The interplay between cardiac metabolism and tumor cell biology: metabolic remodeling","volume":"27","author":"Neumann","year":"2025","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.semcancer.2026.102621_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2022.06.008","article-title":"Cardio-onco-metabolism - metabolic vulnerabilities in cancer and the heart","volume":"171","author":"Karlstaedt","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.semcancer.2026.102621_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-36214-0_4","article-title":"Microenvironment in Cardiac Tumor Development: What Lies Beyond the Event Horizon?","volume":"1226","author":"Mylonas","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102621_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017839","article-title":"Changes in Cardiomyocyte Cell Cycle and Hypertrophic Growth During Fetal to Adult in Mammals","volume":"10","author":"Bishop","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"5923","key":"10.1016\/j.semcancer.2026.102621_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"issue":"6796","key":"10.1016\/j.semcancer.2026.102621_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9412","article-title":"Mechanical load inhibits cancer growth in mouse and human hearts","volume":"392","author":"Ciucci","year":"2026","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaccao.2020.05.009","article-title":"Cardiac Tumors: JACC CardioOncology State-of-the-Art Review","volume":"2","author":"Tyebally","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2459\/JCM.0000000000000059","article-title":"Incidence rate of primary cardiac tumors: a 14-year population study","volume":"17","author":"Cresti","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9149(97)89149-7","article-title":"Frequency of primary tumors of the heart","volume":"77","author":"Reynen","year":"1996","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.hlc.2023.11.005","article-title":"Genetics of Cardiac Tumours: A Narrative Review","volume":"33","author":"AlRasheed","year":"2024","journal-title":"Heart Lung Circ."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102621_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11864-019-0662-1","article-title":"Cardiac Tumors: Clinical Presentation, Diagnosis, and Management","volume":"20","author":"Poterucha","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"20","key":"10.1016\/j.semcancer.2026.102621_bib41","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.12998\/wjcc.v9.i20.5535","article-title":"Multiple left ventricular myxomas combined with severe rheumatic valvular lesions: A case report","volume":"9","author":"Liu","year":"2021","journal-title":"World J. Clin. cases"},{"issue":"02","key":"10.1016\/j.semcancer.2026.102621_bib42","first-page":"3345","article-title":"Advances in Genetic Research of Cardiac Myxoma (in Chinese)","volume":"20","author":"Hong","year":"2020","journal-title":"Mol. Cardiol. China"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s42003-025-08752-y","article-title":"Multi-omics data reveal the origin of cardiac myxoma","volume":"8","author":"Liu","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.2005.035105","article-title":"Cardiac metastases","volume":"60","author":"Bussani","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41420-023-01792-5","article-title":"Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets","volume":"10","author":"Luan","year":"2024","journal-title":"Cell. Death Discov."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cell.2014.03.032","article-title":"The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response","volume":"157","author":"Puente","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s004210100516","article-title":"The expression of lactate transporters (MCT1 and MCT4) in heart and muscle","volume":"86","author":"Bonen","year":"2001","journal-title":"Eur. J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The Science and Translation of Lactate Shuttle Theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell. Metab."},{"issue":"7577","key":"10.1016\/j.semcancer.2026.102621_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.semcancer.2026.102621_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"7860","key":"10.1016\/j.semcancer.2026.102621_bib52","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"issue":"7498","key":"10.1016\/j.semcancer.2026.102621_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"7784","key":"10.1016\/j.semcancer.2026.102621_bib55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib57","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-025-02402-9","article-title":"A two-strata energy flux system driven by a stress hormone prioritizes cardiac energetics","volume":"10","author":"Rao","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.102621_bib60","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib61","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","article-title":"Mitochondria at the crossroads of health and disease","volume":"187","author":"Suomalainen","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib62","doi-asserted-by":"crossref","DOI":"10.2174\/011573403X379197250417061904","article-title":"Mitochondrial Dysfunction in Cardiac Diseases: Insights into Pathophysiology and Clinical Outcomes","volume":"22","author":"Ahmad","year":"2026","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.semcancer.2026.102621_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jare.2025.07.021","article-title":"Mitochondrial cardiovascular diseases: molecular mechanisms, multi-omics exploration and therapeutic strategies","volume":"82","author":"Zhang","year":"2026","journal-title":"J. Adv. Res."},{"issue":"13","key":"10.1016\/j.semcancer.2026.102621_bib64","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib65","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","article-title":"Autophagy and Mitophagy in Cardiovascular Disease","volume":"120","author":"Bravo-San Pedro","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102621_bib68","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102621_bib69","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.stem.2024.10.007","article-title":"CRISPRi\/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity","volume":"31","author":"Liu","year":"2024","journal-title":"Cell. Stem Cell."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: A key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.102621_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155957","article-title":"Lactate and lactylation in cardiovascular diseases: current progress and future perspectives","volume":"158","author":"Zhu","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2026.102621_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101758","article-title":"Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression","volume":"37","author":"Pandkar","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","article-title":"Activation of GPR81 by lactate drives tumour-induced cachexia","volume":"6","author":"Liu","year":"2024","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","article-title":"Ketones and the cardiovascular system","volume":"2","author":"Lopaschuk","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib75","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","article-title":"Ketones and the Heart: Metabolic Principles and Therapeutic Implications","volume":"132","author":"Matsuura","year":"2023","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.cardfail.2025.01.028","article-title":"Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review","volume":"31","author":"Kodur","year":"2025","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101453","article-title":"Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy","volume":"23","author":"Sperry","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cmet.2016.12.010","article-title":"Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth","volume":"25","author":"Xia","year":"2017","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","article-title":"Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress","volume":"27","author":"Schug","year":"2015","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-20-1847","article-title":"Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth","volume":"81","author":"Miller","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.102621_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115741","article-title":"Acetyl-CoA metabolism as a therapeutic target for cancer","volume":"168","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib82","article-title":"Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases","volume":"25","author":"Dato","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib83","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib84","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid Use and Misuse by the Heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib87","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102621_bib88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2024.12.002","article-title":"Theoretical framework and emerging challenges of lipid metabolism in cancer","volume":"108","author":"Gu","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib89","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.cmet.2023.09.012","article-title":"CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression","volume":"35","author":"Terry","year":"2023","journal-title":"Cell. Metab."},{"issue":"7274","key":"10.1016\/j.semcancer.2026.102621_bib90","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib92","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10545-016-9960-y","article-title":"A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model","volume":"39","author":"Wang","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib93","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41375-020-01043-x","article-title":"IDH1\/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis","volume":"35","author":"Kattih","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","article-title":"Succinate: a metabolic signal in inflammation","volume":"24","author":"Mills","year":"2014","journal-title":"Trends Cell. Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109246","article-title":"Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1\/GPR91-mediated Gq signaling","volume":"35","author":"Trauelsen","year":"2021","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12929-022-00878-z","article-title":"Cancer-derived extracellular succinate: a driver of cancer metastasis","volume":"29","author":"Kuo","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib99","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2012.01.017","article-title":"Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway","volume":"15","author":"Ashrafian","year":"2012","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaccao.2023.10.002","article-title":"Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway","volume":"6","author":"Tani","year":"2024","journal-title":"JACC CardioOncol"},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib102","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-21-2463","article-title":"Cardiac Dysfunction Promotes Cancer Progression via Multiple Secreted Factors","volume":"82","author":"Awwad","year":"2022","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib103","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.120.046471","article-title":"Early Cardiac Remodeling Promotes Tumor Growth and Metastasis","volume":"142","author":"Avraham","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-Carbon Metabolism in Health and Disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell. Metab."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102621_bib105","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib106","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib107","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7407","key":"10.1016\/j.semcancer.2026.102621_bib108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.semcancer.2026.102621_bib109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","article-title":"Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure","volume":"119","author":"Sager","year":"2016","journal-title":"Circ. Res."},{"issue":"22","key":"10.1016\/j.semcancer.2026.102621_bib110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.123.066911","article-title":"Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth","volume":"149","author":"Caller","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-023-01336-4","article-title":"Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib112","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cmet.2024.03.008","article-title":"Futile cycles: Emerging utility from apparent futility","volume":"36","author":"Sharma","year":"2024","journal-title":"Cell. Metab."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib113","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamacardio.2019.0302","article-title":"Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review","volume":"4","author":"Calvillo-Arguelles","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib114","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaccao.2025.06.006","article-title":"Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review","volume":"7","author":"Evans","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"6514","key":"10.1016\/j.semcancer.2026.102621_bib115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib116","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","article-title":"Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity","volume":"9","author":"Wu","year":"2024","journal-title":"JACC Basic. Transl. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib117","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib118","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib119","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11864-024-01203-6","article-title":"Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods","volume":"25","author":"Kuang","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"issue":"41","key":"10.1016\/j.semcancer.2026.102621_bib120","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib121","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s42255-023-00817-8","article-title":"A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation","volume":"5","author":"Benedetti","year":"2023","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib122","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11306-025-02258-8","article-title":"A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity","volume":"21","author":"Singh","year":"2025","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib123","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbad005","article-title":"Circulating metabolic signatures of heart failure in precision cardiology","volume":"6","author":"Xie","year":"2023","journal-title":"Precis. Clin. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib124","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular Metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcancer.2026.102621_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1393930","article-title":"Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles","volume":"14","author":"Silver","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/biom14020199","article-title":"Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond","volume":"14","author":"Attanasio","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib127","first-page":"17","article-title":"Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients","volume":"11","author":"Lal","year":"2025","journal-title":"Cardiooncology"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12265-019-09927-9","article-title":"Metabolic Imaging in Cardio-oncology","volume":"13","author":"Tong","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41391-019-0180-z","article-title":"Hyperpolarized (13)C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study","volume":"23","author":"Chen","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101095","article-title":"Hyperpolarized [1-(13)C]pyruvate cardiovascular magnetic resonance imaging identifies metabolic phenotypes in patients with heart failure","volume":"26","author":"Joergensen","year":"2024","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102621_bib131","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.120.317970","article-title":"Effect of Doxorubicin on Myocardial Bicarbonate Production From Pyruvate Dehydrogenase in Women With Breast Cancer","volume":"127","author":"Park","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib132","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s12350-018-1206-y","article-title":"Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using (11)C-acetate PET","volume":"25","author":"Wu","year":"2018","journal-title":"J. Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib133","article-title":"Effectiveness of Iodine-123 beta-methyl-P-iodophenyl-pentadecanoic acid (BMIPP) Myocardial Scintigraphy for Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD) in Breast Cancer Patients","volume":"14","author":"Harada","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib134","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11886-022-01641-4","article-title":"PET Tracers for Imaging Cardiac Function in Cardio-oncology","volume":"24","author":"Kelly","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib135","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/RES.0000000000000097","article-title":"S. American Heart Association Council on Basic Cardiovascular, Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association","volume":"118","author":"Taegtmeyer","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib136","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10741-017-9616-5","article-title":"T2 mapping and T2* imaging in heart failure","volume":"22","author":"Lota","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102621_bib137","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacbts.2018.02.003","article-title":"Vivo reactive oxygen species detection with a novel positron emission tomography tracer, (18)F-DHMT, allows for early detection of anthracycline-induced cardiotoxicity in rodents","volume":"3","author":"Boutagy","year":"2018","journal-title":"JACC Basic. Transl. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib138","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.2967\/jnumed.122.264868","article-title":"Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives","volume":"64","author":"Kersting","year":"2023","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib139","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"116","key":"10.1016\/j.semcancer.2026.102621_bib140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002693","article-title":"Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy","volume":"4","author":"Andronesi","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"33","key":"10.1016\/j.semcancer.2026.102621_bib141","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1200\/JCO.2016.67.1222","article-title":"Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma","volume":"34","author":"Choi","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib142","first-page":"53","article-title":"Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis","volume":"10","author":"Tong","year":"2024","journal-title":"Cardiooncology"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib143","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s44303-024-00025-3","article-title":"Mass spectrometry imaging for spatially resolved multi-omics molecular mapping","volume":"2","author":"Zhang","year":"2024","journal-title":"Npj Imaging"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70031","article-title":"Spatially resolved metabolomics: From metabolite mapping to function visualising","volume":"14","author":"Min","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"24","key":"10.1016\/j.semcancer.2026.102621_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202502028","article-title":"Integrating Ambient Ionization Mass Spectrometry Imaging and Spatial Transcriptomics on the Same Cancer Tissues to Identify RNA-Metabolite Correlations","volume":"64","author":"Godfrey","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib146","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41587-020-0651-8","article-title":"Single-cell metabolic profiling of human cytotoxic T cells","volume":"39","author":"Hartmann","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib147","article-title":"Combined spatial metabolomics and 4D-DIA quantitative proteomics approaches to explore the relationship between lung cancer and the heart","volume":"15","author":"Bai","year":"2025","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102621_bib148","article-title":"Cardiometabolic disease and cardio-oncology: Insights from iPSC models and tissue engineering","volume":"6","author":"Kojic","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib149","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4196\/kjpp.24.413","article-title":"Human induced pluripotent stem cell-cardiomyocytes for cardiotoxicity assessment: a comparative study of arrhythmiainducing drugs with multi-electrode array analysis","volume":"29","author":"Park","year":"2025","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102621_bib150","article-title":"A Heart-Breast Cancer-on-a-Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy","volume":"17","author":"Lee","year":"2021","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102621_bib151","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011876","article-title":"Insights from living myocardial slices into chemotherapy-induced cardiotoxicity: a novel Ex vivo tool to guide clinical decision-making","volume":"18","author":"Kelters","year":"2025","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102621_bib152","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib153","first-page":"83","volume":"7","author":"Bonaca","year":"2025","journal-title":"Cardiovasc. Saf. Oncol. Clin. Trial. JACC CardioOncology Prim. JACC CardioOncol"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib154","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-18-3749","article-title":"FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation","volume":"25","author":"Norsworthy","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"25","key":"10.1016\/j.semcancer.2026.102621_bib155","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102621_bib156","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/bloodadvances.2023012302","article-title":"Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed\/refractory myelodysplastic syndrome","volume":"8","author":"DiNardo","year":"2024","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib157","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib158","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaccao.2024.02.004","article-title":"Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines: JACC: CardioOncology Controversies in Cardio-Oncology","volume":"6","author":"Upshaw","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.semcancer.2026.102621_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD014638.pub2","article-title":"Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines","author":"de Baat","year":"2022","journal-title":"Cochrane Database Syst. Rev. 9(9"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102621_bib160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","article-title":"Clinically translatable prevention of anthracycline cardiotoxicity by dexrazoxane is mediated by topoisomerase II beta and not metal chelation","volume":"14","author":"Jirkovsky","year":"2021","journal-title":"Circ. Heart Fail."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102621_bib161","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102621_bib162","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102621_bib163","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaccao.2024.01.007","article-title":"The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Dabour","year":"2024","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.semcancer.2026.102621_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104780","article-title":"SGLT2 inhibitors in cancer patients: a comprehensive review of clinical, biochemical, and therapeutic implications in cardio-oncology","volume":"26","author":"Greco","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.102621_bib165","unstructured":"Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines (EMPACT). https:\/\/clinicaltrials.gov\/study\/NCT05271162. (Accessed 02.08.2026)."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102621_bib166","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","article-title":"Tumour fatty acid metabolism in the context of therapy resistance and obesity","volume":"21","author":"Hoy","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102621_bib167","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.102621_bib168","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2024.04.011","article-title":"AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats","volume":"191","author":"Choksey","year":"2024","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:51:05Z","timestamp":1793098265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X2600088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":168,"alternative-id":["S1044579X2600088X"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102621","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic drivers of bidirectional heart\u2013cancer crosstalk: From a relatively tumor-restrictive myocardium to therapeutic decoupling","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102621"}}